Previous studies in myeloproliferative neoplasms and colorectal cancer, indicated that TSA treatment increases the SOCS3 expression, and this increase repressed the cell growth in both type of cancers [25,42]. This evidence concerns the gene SOCS3 and myeloproliferative disorder.